The honest reference.

Cost guides, regulatory explainers, and treatment-timeline references. Sourced, dated, and updated when the underlying facts change.

GLP-1 · News & analysis

FDA's compounded-semaglutide ban: what changes for patients in 2026

The April 30, 2026 503B bulks-list proposal closes the cheapest path to GLP-1 medication for millions. Here's what's still legal, what the timeline looks like, and which providers are credible alternatives.

Updated 2026-05-14 · 12 min read

GLP-1 · Cost guide

How much does semaglutide actually cost in 2026?

All-in twelve-month math across Wegovy, Ozempic, compounded, and sublingual options. The honest numbers, with every line item itemized and sourced.

In production · publishing this week

Also in the queue

→Wegovy vs. compounded semaglutide: same molecule, different math (and different legal status)
→The 90-day GLP-1 clinical timeline: when results actually happen, and why most quit at week 6
→Tirzepatide vs. semaglutide: what the SURMOUNT and STEP trials say
→The full hair-loss timeline: shedding, regrowth, and the week-6 quit point
→Online ADHD evaluation in 2026: what's still possible after the DEA crackdown